Powder: -20°C for 3 years | In solvent: -80°C for 1 year
HN37 as a potent and chemically stable antiepileptic drug candidate, with an EC 50 of 37 nM for KCNQ2 [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,980.00 | |
50 mg | 6-8 weeks | $ 2,650.00 |
Description | HN37 as a potent and chemically stable antiepileptic drug candidate, with an EC 50 of 37 nM for KCNQ2 [1]. |
In vitro | HN37 is a potent neuronal Kv7 activator with a subtype selectivity similar to RTG [1]. |
Molecular Weight | 340.39 |
Formula | C20H21FN2O2 |
CAS No. | 1821222-10-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
HN37 1821222-10-9 inhibitor inhibit